| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.909 | 0.003 | 0.926 | Caspase 9 stimulant | 0.926 0.002 CHEMBL873 0.892 0.003 CHEMBL875 0.875 0.004 CHEMBL874 0.582 0.039 CHEMBL872 | CHEMBL873 | |
| 0.838 | 0.004 | 0.838 | Caspase 3 stimulant | 0.838 0.004 CHEMBL873 0.821 0.004 CHEMBL875 0.785 0.004 CHEMBL874 0.732 0.005 CHEMBL872 | ||
| 0.838 | 0.011 | 0.839 | Antiinflammatory | 0.839 0.01 CHEMBL873 0.798 0.016 CHEMBL875 0.819 0.013 CHEMBL874 0.804 0.015 CHEMBL872 | CHEMBL873 | |
| 0.793 | 0.001 | 0.793 | Catenin beta inhibitor | 0.778 0.001 CHEMBL873 0.768 0.001 CHEMBL875 0.744 0.002 CHEMBL874 0.718 0.002 CHEMBL872 | ||
| 0.652 | 0.002 | 0.654 | Vanilloid agonist | 0.654 0.002 CHEMBL873 0.598 0.003 CHEMBL875 0.549 0.003 CHEMBL874 0.481 0.003 CHEMBL872 | CHEMBL873 | |
| 0.61 | 0.004 | 0.61 | Non-steroidal antiinflammatory agent | 0.608 0.004 CHEMBL873 0.575 0.005 CHEMBL875 0.428 0.01 CHEMBL874 0.239 0.048 CHEMBL872 | ||
| 0.509 | 0.002 | 0.587 | Vanilloid 1 agonist | 0.587 0.002 CHEMBL873 0.456 0.003 CHEMBL875 0.236 0.006 CHEMBL874 0.203 0.011 CHEMBL872 | CHEMBL873 | |
| 0.47 | 0.017 | 0.504 | DNA damaging | 0.503 0.013 CHEMBL873 0.504 0.013 CHEMBL875 0.402 0.028 CHEMBL874 0.433 0.022 CHEMBL872 | CHEMBL875 | |
| 0.487 | 0.046 | 0.615 | Transcription factor NF kappa B inhibitor | 0.615 0.029 CHEMBL873 0.529 0.04 CHEMBL875 0.369 0.071 CHEMBL874 0.373 0.07 CHEMBL872 | CHEMBL873 | |
| 0.511 | 0.071 | 0.566 | Apoptosis agonist | 0.566 0.057 CHEMBL873 0.556 0.059 CHEMBL875 0.391 0.118 CHEMBL874 0.272 0.193 CHEMBL872 | CHEMBL873 | |
| 0.416 | 0.006 | 0.42 | Cyclooxygenase 1 inhibitor | 0.42 0.006 CHEMBL873 0.396 0.007 CHEMBL875 0.299 0.014 CHEMBL874 0.232 0.025 CHEMBL872 | CHEMBL873 | |
| 0.384 | 0.025 | 0.384 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.361 0.032 CHEMBL873 0.322 0.049 CHEMBL872 | ||
| 0.365 | 0.01 | 0.365 | Cyclooxygenase inhibitor | 0.357 0.01 CHEMBL873 0.341 0.012 CHEMBL875 0.275 0.022 CHEMBL874 0.227 0.032 CHEMBL872 | ||
| 0.361 | 0.014 | 0.402 | Tyrosine 3 hydroxylase inhibitor | 0.402 0.008 CHEMBL873 0.384 0.01 CHEMBL875 0.277 0.046 CHEMBL874 0.216 0.11 CHEMBL872 | CHEMBL873 | |
| 0.331 | 0.01 | 0.331 | Cyclooxygenase 2 inhibitor | 0.319 0.011 CHEMBL873 0.306 0.013 CHEMBL875 0.247 0.02 CHEMBL874 0.196 0.032 CHEMBL872 | ||
| 0.406 | 0.088 | 0.43 | Cyclophilin D inhibitor | 0.408 0.087 CHEMBL873 0.327 0.14 CHEMBL875 0.43 0.075 CHEMBL874 | CHEMBL874 | |
| 0.378 | 0.063 | 0.394 | Vasodilator, peripheral | 0.394 0.057 CHEMBL873 0.273 0.111 CHEMBL875 0.264 0.117 CHEMBL874 | CHEMBL873 | |
| 0.289 | 0.005 | 0.289 | GABA C receptor antagonist | 0.258 0.006 CHEMBL873 0.252 0.006 CHEMBL875 0.163 0.024 CHEMBL874 0.101 0.077 CHEMBL872 | ||
| 0.279 | 0.003 | 0.289 | Arachidonic acid antagonist | 0.289 0.002 CHEMBL873 0.28 0.003 CHEMBL875 0.248 0.006 CHEMBL874 0.202 0.031 CHEMBL872 | CHEMBL873 | |
| 0.268 | 0.009 | 0.268 | GABA C receptor rho-2 antagonist | 0.256 0.01 CHEMBL873 0.249 0.012 CHEMBL875 0.162 0.059 CHEMBL874 | ||
| 0.257 | 0.004 | 0.257 | GABA C receptor rho-1 antagonist | 0.223 0.005 CHEMBL873 0.216 0.006 CHEMBL875 0.15 0.021 CHEMBL874 0.095 0.07 CHEMBL872 | ||
| 0.355 | 0.113 | 0.494 | Calcium channel L-type activator | 0.352 0.116 CHEMBL873 0.342 0.123 CHEMBL875 0.494 0.03 CHEMBL874 0.262 0.193 CHEMBL872 | CHEMBL874 | |
| 0.202 | 0.013 | 0.213 | Antineoplastic alkaloid | 0.207 0.012 CHEMBL873 0.213 0.01 CHEMBL875 0.122 0.037 CHEMBL874 0.088 0.057 CHEMBL872 | CHEMBL875 | |
| 0.228 | 0.041 | 0.231 | Lipocortins synthesis antagonist | 0.231 0.04 CHEMBL873 0.217 0.047 CHEMBL875 0.204 0.054 CHEMBL874 0.135 0.13 CHEMBL872 | CHEMBL873 | |
| 0.298 | 0.112 | 0.487 | Toll-Like receptor agonist | 0.294 0.115 CHEMBL873 0.4 0.06 CHEMBL874 0.487 0.034 CHEMBL872 | CHEMBL872 | |
| 0.193 | 0.007 | 0.208 | Peroxisome proliferator-activated receptor gamma agonist | 0.182 0.008 CHEMBL873 0.208 0.006 CHEMBL875 0.157 0.011 CHEMBL874 0.112 0.022 CHEMBL872 | CHEMBL875 | |
| 0.305 | 0.121 | 0.352 | Histamine release inhibitor | 0.352 0.099 CHEMBL873 0.23 0.172 CHEMBL875 | CHEMBL873 | |
| 0.296 | 0.112 | 0.487 | Toll-Like receptor 7 agonist | 0.293 0.115 CHEMBL873 0.403 0.059 CHEMBL874 0.487 0.034 CHEMBL872 | CHEMBL872 | |
| 0.263 | 0.091 | 0.372 | Lipoxygenase inhibitor | 0.372 0.045 CHEMBL873 0.316 0.063 CHEMBL875 0.189 0.152 CHEMBL874 0.281 0.081 CHEMBL872 | CHEMBL873 | |
| 0.216 | 0.048 | 0.25 | Mcl-1 antagonist | 0.25 0.036 CHEMBL873 0.241 0.039 CHEMBL875 | CHEMBL873 | |
| 0.272 | 0.105 | 0.325 | Sodium/bile acid cotransporter inhibitor | 0.325 0.058 CHEMBL873 0.316 0.065 CHEMBL875 0.285 0.093 CHEMBL874 | CHEMBL873 | |
| 0.176 | 0.029 | 0.2 | MAP3K9 inhibitor | 0.172 0.033 CHEMBL873 0.166 0.04 CHEMBL875 0.2 0.015 CHEMBL874 | CHEMBL874 | |
| 0.155 | 0.009 | 0.166 | Leukotriene synthesis inhibitor | 0.166 0.007 CHEMBL873 0.161 0.008 CHEMBL875 0.155 0.009 CHEMBL874 0.133 0.013 CHEMBL872 | CHEMBL873 | |
| 0.15 | 0.004 | 0.16 | Nicotinic acid receptor agonist | 0.16 0.004 CHEMBL873 0.092 0.005 CHEMBL875 0.055 0.013 CHEMBL874 | CHEMBL873 | |
| 0.253 | 0.124 | 0.267 | Antithrombotic | 0.267 0.113 CHEMBL873 0.229 0.145 CHEMBL875 0.247 0.128 CHEMBL874 | CHEMBL873 | |
| 0.201 | 0.073 | 0.207 | Insulin sensitizer | 0.207 0.067 CHEMBL873 0.169 0.108 CHEMBL875 0.161 0.119 CHEMBL874 | CHEMBL873 | |
| 0.153 | 0.029 | 0.153 | Photosensitizer | 0.152 0.03 CHEMBL873 0.131 0.045 CHEMBL875 0.148 0.032 CHEMBL874 | ||
| 0.184 | 0.071 | 0.184 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.162 0.082 CHEMBL873 0.127 0.109 CHEMBL872 | ||
| 0.288 | 0.178 | 0.288 | 5 Hydroxytryptamine release inhibitor | 0.282 0.186 CHEMBL873 0.284 0.184 CHEMBL874 | ||
| 0.193 | 0.084 | 0.241 | Neurotrophic factor enhancer | 0.241 0.044 CHEMBL873 0.231 0.051 CHEMBL875 | CHEMBL873 | |
| 0.191 | 0.083 | 0.191 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.175 0.1 CHEMBL873 0.153 0.124 CHEMBL872 | ||
| 0.236 | 0.135 | 0.274 | Interleukin 2 agonist | 0.262 0.106 CHEMBL873 0.269 0.099 CHEMBL875 0.274 0.094 CHEMBL874 0.21 0.173 CHEMBL872 | CHEMBL874 | |
| 0.116 | 0.02 | 0.116 | Glycine receptor antagonist | 0.093 0.039 CHEMBL873 0.107 0.026 CHEMBL875 0.079 0.058 CHEMBL874 | ||
| 0.1 | 0.005 | 0.173 | HCV NS5B polymerase inhibitor | 0.115 0.004 CHEMBL873 0.173 0.004 CHEMBL875 0.042 0.013 CHEMBL874 | CHEMBL875 | |
| 0.2 | 0.113 | 0.32 | Antioxidant | 0.32 0.055 CHEMBL873 0.283 0.069 CHEMBL875 0.222 0.1 CHEMBL874 | CHEMBL873 | |
| 0.089 | 0.007 | 0.09 | Nicotinic acid receptor 2 agonist | 0.09 0.007 CHEMBL873 0.074 0.009 CHEMBL875 0.054 0.013 CHEMBL874 0.038 0.022 CHEMBL872 | CHEMBL873 | |
| 0.201 | 0.121 | 0.215 | DNA synthesis inhibitor | 0.213 0.103 CHEMBL873 0.215 0.101 CHEMBL875 0.177 0.158 CHEMBL874 0.191 0.137 CHEMBL872 | CHEMBL875 | |
| 0.252 | 0.18 | 0.327 | Analgesic | 0.244 0.188 CHEMBL873 0.225 0.209 CHEMBL874 0.327 0.122 CHEMBL872 | CHEMBL872 | |
| 0.066 | 0.01 | 0.066 | Sphingosine 1-phosphate receptor 1 agonist | 0.05 0.02 CHEMBL873 0.042 0.03 CHEMBL875 | ||
| 0.108 | 0.057 | 0.2 | 5-Lipoxygenase inhibitor | 0.155 0.036 CHEMBL873 0.141 0.041 CHEMBL875 0.081 0.08 CHEMBL874 0.2 0.024 CHEMBL872 | CHEMBL872 | |
| 0.185 | 0.135 | 0.185 | 5 Hydroxytryptamine release stimulant | 0.175 0.146 CHEMBL873 | ||
| 0.062 | 0.015 | 0.062 | Sphingosine 1-phosphate receptor agonist | 0.043 0.032 CHEMBL873 | ||
| 0.056 | 0.011 | 0.056 | RNA-directed RNA polymerase inhibitor | 0.053 0.012 CHEMBL873 0.054 0.011 CHEMBL875 | ||
| 0.106 | 0.061 | 0.106 | GABA C receptor agonist | 0.095 0.072 CHEMBL873 0.095 0.072 CHEMBL875 | ||
| 0.079 | 0.035 | 0.079 | Peroxisome proliferator-activated receptor gamma antagonist | 0.073 0.045 CHEMBL873 0.074 0.044 CHEMBL875 0.07 0.054 CHEMBL874 | ||
| 0.069 | 0.027 | 0.069 | Prostaglandin antagonist | 0.048 0.041 CHEMBL874 | ||
| 0.119 | 0.078 | 0.119 | Alpha-N-acetylglucosaminidase inhibitor | |||
| 0.148 | 0.11 | 0.167 | Phospholipase C inhibitor | 0.167 0.077 CHEMBL873 0.163 0.083 CHEMBL875 0.16 0.087 CHEMBL872 | CHEMBL873 | |
| 0.038 | 0.009 | 0.038 | Prostaglandin D2 antagonist | 0.024 0.015 CHEMBL873 0.027 0.013 CHEMBL874 | ||
| 0.033 | 0.012 | 0.033 | Kainate receptor 4 antagonist | 0.023 0.019 CHEMBL873 0.026 0.016 CHEMBL875 | ||
| 0.038 | 0.017 | 0.042 | Melatonin 2 agonist | 0.042 0.014 CHEMBL873 | CHEMBL873 | |
| 0.094 | 0.075 | 0.148 | Topoisomerase I inhibitor | 0.148 0.042 CHEMBL873 0.123 0.054 CHEMBL875 | CHEMBL873 | |
| 0.032 | 0.016 | 0.035 | Liver X receptor alpha antagonist | 0.035 0.012 CHEMBL873 | CHEMBL873 | |
| 0.035 | 0.02 | 0.035 | Peroxisome proliferator-activated receptor delta antagonist | 0.033 0.023 CHEMBL873 0.032 0.026 CHEMBL875 | ||
| 0.044 | 0.031 | 0.052 | NMDA receptor subunit 3B antagonist | 0.052 0.023 CHEMBL873 | CHEMBL873 | |
| 0.035 | 0.025 | 0.035 | Retinoid X receptor agonist | |||
| 0.091 | 0.081 | 0.19 | Ferrochelatase inhibitor | 0.19 0.025 CHEMBL874 | CHEMBL874 | |
| 0.037 | 0.027 | 0.046 | NMDA receptor subunit 3A antagonist | 0.046 0.022 CHEMBL873 | CHEMBL873 | |
| 0.083 | 0.075 | 0.102 | Alcohol dehydrogenase inhibitor | 0.102 0.051 CHEMBL873 | CHEMBL873 | |
| 0.077 | 0.069 | 0.089 | NMDA receptor antagonist | 0.089 0.055 CHEMBL873 | CHEMBL873 | |
| 0.044 | 0.037 | 0.049 | Peroxisome proliferator-activated receptor alpha agonist | 0.049 0.033 CHEMBL875 | CHEMBL875 | |
| 0.03 | 0.023 | 0.033 | Liver X receptor antagonist | 0.033 0.019 CHEMBL873 | CHEMBL873 | |
| 0.135 | 0.131 | 0.136 | Anesthetic general | 0.135 0.131 CHEMBL873 0.136 0.13 CHEMBL875 | CHEMBL875 | |
| 0.13 | 0.125 | 0.151 | Interleukin 6 antagonist | 0.132 0.12 CHEMBL873 0.151 0.087 CHEMBL875 0.148 0.092 CHEMBL872 | CHEMBL875 | |
| 0.017 | 0.013 | 0.017 | Kainate receptor 3 antagonist | |||
| 0.019 | 0.016 | 0.019 | Kainate receptor 5 antagonist | |||
| 0.03 | 0.028 | 0.033 | Melatonin 1 agonist | 0.033 0.023 CHEMBL873 | CHEMBL873 | |
| 0.031 | 0.028 | 0.031 | Progesterone antagonist | 0.03 0.029 CHEMBL873 | ||
| 0.12 | 0.117 | 0.127 | CC chemokine 6 receptor antagonist | 0.127 0.082 CHEMBL875 | CHEMBL875 | |
| 0.064 | 0.061 | 0.064 | MDM2 inhibitor | |||
| 0.036 | 0.035 | 0.036 | AMPA 4 receptor antagonist | |||
| 0.027 | 0.033 | 0.029 | Melatonin agonist | 0.029 0.028 CHEMBL873 | CHEMBL873 | |
| 0.14 | 0.147 | 0.165 | Hypolipemic | 0.165 0.122 CHEMBL875 0.157 0.129 CHEMBL874 | CHEMBL875 | |
| 0.063 | 0.07 | 0.067 | CDC25A inhibitor | 0.067 0.061 CHEMBL873 | CHEMBL873 | |
| 0.02 | 0.03 | 0.023 | Lysophosphatidic acid receptor 1 agonist | 0.023 0.022 CHEMBL874 | CHEMBL874 | |
| 0.054 | 0.065 | 0.059 | Cyclin B3 inhibitor | 0.059 0.057 CHEMBL873 | CHEMBL873 | |
| 0.053 | 0.064 | 0.07 | Phosphofructokinase-1 inhibitor | 0.07 0.048 CHEMBL875 | CHEMBL875 | |
| 0.053 | 0.076 | 0.151 | Phosphodiesterase V inhibitor | 0.151 0.01 CHEMBL875 | CHEMBL875 | |
| 0.011 | 0.035 | 0.015 | Thyroid hormone alpha agonist | 0.015 0.013 CHEMBL875 | CHEMBL875 | |
| 0.012 | 0.037 | 0.018 | Somatostatin 3 antagonist | 0.018 0.016 CHEMBL874 | CHEMBL874 | |
| 0.051 | 0.08 | 0.063 | Sirtuin 1 inhibitor | 0.063 0.055 CHEMBL875 | CHEMBL875 | |
| 0.129 | 0.158 | 0.144 | Succinate dehydrogenase inhibitor | 0.144 0.124 CHEMBL875 | CHEMBL875 | |
| 0.141 | 0.17 | 0.204 | Cyclic AMP phosphodiesterase inhibitor | 0.163 0.131 CHEMBL873 0.204 0.091 CHEMBL874 | CHEMBL874 | |
| 0.134 | 0.164 | 0.18 | Platelet antagonist | 0.18 0.117 CHEMBL874 | CHEMBL874 | |
| 0.05 | 0.082 | 0.152 | Phosphodiesterase 5A inhibitor | 0.152 0.01 CHEMBL875 | CHEMBL875 | |
| 0.09 | 0.123 | 0.136 | Estrogen antagonist | 0.136 0.031 CHEMBL873 0.122 0.051 CHEMBL875 | CHEMBL873 | |
| 0.032 | 0.071 | 0.056 | Mineralocorticoid receptor antagonist | 0.056 0.024 CHEMBL872 | CHEMBL872 | |
| 0.065 | 0.106 | 0.206 | Phosphodiesterase XI inhibitor | 0.206 0.004 CHEMBL875 | CHEMBL875 | |
| 0.065 | 0.106 | 0.206 | Phosphodiesterase 11A inhibitor | 0.206 0.004 CHEMBL875 | CHEMBL875 | |
| 0.103 | 0.147 | 0.137 | Farnesoid X receptor antagonist | 0.137 0.07 CHEMBL873 0.135 0.073 CHEMBL875 | CHEMBL873 | |
| 0.072 | 0.116 | 0.1 | Anabolic | 0.1 0.062 CHEMBL873 | CHEMBL873 | |
| 0.009 | 0.057 | 0.057 | Melatonin 1 antagonist | 0.057 0.005 CHEMBL872 | CHEMBL872 | |
| 0.045 | 0.096 | 0.072 | Porphobilinogen synthase inhibitor | 0.072 0.054 CHEMBL875 | CHEMBL875 | |
| 0.109 | 0.161 | 0.147 | Melanin inhibitor | 0.147 0.086 CHEMBL873 | CHEMBL873 | |
| 0.141 | 0.197 | 0.185 | Hypoglycemic | 0.181 0.132 CHEMBL873 0.185 0.128 CHEMBL874 | CHEMBL874 | |
| 0.058 | 0.114 | 0.082 | Estrogen receptor alpha antagonist | 0.082 0.046 CHEMBL873 0.072 0.063 CHEMBL875 | CHEMBL873 | |
| 0.015 | 0.072 | 0.025 | Thyroid hormone agonist | 0.025 0.02 CHEMBL873 | CHEMBL873 | |
| 0.01 | 0.079 | 0.077 | Melatonin antagonist | 0.077 0.005 CHEMBL872 | CHEMBL872 | |
| 0.065 | 0.136 | 0.12 | Estrogen receptor beta antagonist | 0.12 0.032 CHEMBL873 0.109 0.048 CHEMBL875 | CHEMBL873 | |
| 0.038 | 0.113 | 0.064 | Histidine decarboxylase inhibitor | 0.064 0.058 CHEMBL873 | CHEMBL873 | |
| 0.062 | 0.143 | 0.09 | Lanosterol 14 alpha demethylase inhibitor | 0.09 0.071 CHEMBL874 | CHEMBL874 | |
| 0.072 | 0.16 | 0.108 | DOPA decarboxylase inhibitor | 0.108 0.062 CHEMBL873 0.101 0.075 CHEMBL875 | CHEMBL873 | |
| 0.019 | 0.113 | 0.03 | Estrogen-related receptor beta antagonist | 0.03 0.029 CHEMBL873 | CHEMBL873 | |
| 0.041 | 0.139 | 0.064 | Potassium channel large-conductance Ca-activated activator | 0.064 0.053 CHEMBL875 | CHEMBL875 | |
| 0.169 | 0.267 | 0.208 | Calcium channel activator | 0.208 0.201 CHEMBL874 | CHEMBL874 | |
| 0.108 | 0.211 | 0.227 | Free radical scavenger | 0.227 0.079 CHEMBL873 0.219 0.084 CHEMBL875 | CHEMBL873 | |
| 0.099 | 0.209 | 0.167 | Aldehyde oxidase inhibitor | 0.167 0.125 CHEMBL873 | CHEMBL873 | |
| 0.048 | 0.158 | 0.104 | Protein-tyrosine phosphatase 1B inhibitor | 0.104 0.074 CHEMBL875 | CHEMBL875 | |
| 0.035 | 0.15 | 0.09 | Phosphodiesterase IV inhibitor | 0.09 0.053 CHEMBL874 | CHEMBL874 | |
| 0.064 | 0.184 | 0.112 | Phosphodiesterase inhibitor | 0.112 0.091 CHEMBL875 | CHEMBL875 | |
| 0.13 | 0.26 | 0.191 | Peptidyltransferase inhibitor | 0.191 0.111 CHEMBL874 | CHEMBL874 | |
| 0.072 | 0.206 | 0.138 | Protein-tyrosine phosphatase inhibitor | 0.138 0.092 CHEMBL875 | CHEMBL875 | |
| 0.061 | 0.196 | 0.139 | Lipid peroxidase inhibitor | 0.139 0.076 CHEMBL873 0.108 0.106 CHEMBL875 0.11 0.104 CHEMBL874 | CHEMBL873 | |
| 0.015 | 0.156 | 0.064 | Prostaglandin EP2 antagonist | 0.064 0.038 CHEMBL874 | CHEMBL874 | |
| 0.079 | 0.245 | 0.189 | Potassium channel (Voltage-sensitive) blocker | 0.189 0.103 CHEMBL874 | CHEMBL874 | |
| 0.118 | 0.306 | 0.203 | Immunosuppressant | 0.203 0.194 CHEMBL874 | CHEMBL874 | |
| 0.01 | 0.215 | 0.026 | Phosphodiesterase 6A inhibitor | 0.026 0.011 CHEMBL875 | CHEMBL875 | |
| 0.008 | 0.245 | 0.026 | Tryptophan hydroxylase 1 inhibitor | 0.026 0.004 CHEMBL874 | CHEMBL874 | |
| 0.043 | 0.292 | 0.103 | Nav1.4 sodium channel blocker | 0.103 0.072 CHEMBL874 | CHEMBL874 | |
| 0.023 | 0.386 | 0.089 | Somatostatin 1 agonist | 0.07 0.065 CHEMBL874 0.089 0.042 CHEMBL872 | CHEMBL872 | |
| 0.021 | 0.43 | 0.104 | Aminoacyl-tRNA synthetase inhibitor | 0.104 0.041 CHEMBL872 | CHEMBL872 | |
| 0.023 | 0.624 | 0.083 | Interleukin 5 antagonist | 0.083 0.067 CHEMBL874 | CHEMBL874 | |
| 0.014 | 0.664 | 0.271 | Antiviral (Hepatitis D) | 0.271 0.002 CHEMBL872 | CHEMBL872 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |